# Intellia Therapeutics, Inc. — Form D

Intellia Therapeutics, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2015-09-03. The offering totals $70.0M, of which $70.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2015-09-03
- Form: D
- Accession: 0001652130-15-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $70.0M
- Amount sold: $70.0M
- Investors: 28
- Date of first sale: 2015-08-20
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-247004

## Issuer

- Name: Intellia Therapeutics, Inc.
- CIK: 0001652130
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 130 BROOKLINE STREET, CAMBRIDGE, MA, 02139
- Phone: 857-285-6200

## Officers, directors & promoters (8)

| Name | Role | Location |
| --- | --- | --- |
| Nessan Bermingham | Director | Cary, NC |
| Jean-Francois Formela | Director | Cambridge, MA |
| CARL GORDON | Director | SAN DIEGO, CA |
| Rachel Haurwitz | Director | CAMBRIDGE, MA |
| John Leonard | Director | BOSTON, MA |
| Nessan Bermingham | Executive Officer | Cary, NC |
| John Leonard | Executive Officer | BOSTON, MA |
| Jose Rivera | Executive Officer | CAMBRIDGE, MA |

## More

- [CIK 1652130 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1652130&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001652130-15-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.